P110δ-IN-1
P110δ-IN-1 is a potent and selective inhibitor of P110δ extracted from patent WO 2014055647 A1, with an IC50 of 8.4 nM[1].
Product Specifications
CAS Number
[1595129-71-7]
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/p110-delta-in-1.html
Purity
98.44
Solubility
DMSO : 4.62 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=S(C1=NC2=CC=CC=C2N1C3=NC(N4CCOCC4)=NC(NC(C)(C)CC5=CC=CC=C5C6CCN(C)CC6)=N3)(C)=O
Molecular Formula
C31H40N8O3S
Molecular Weight
604.77
References & Citations
[1]S. David Brown , et al. (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases. WO2014055647A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
397589 100 µg
TRAF3 (TNF Receptor-Associated Factor 3, CAP-1, CD40 Receptor-Associated Factor 1, CRAF1, CD40-Binding Protein, CD40BP, LMP1-Associated Protein 1, LAP1, RING-Type E3 Ubiquitin Transferase TRAF3, CAP1, CRAF1)
Ask
View Details 
